Details for New Drug Application (NDA): 020928
✉ Email this page to a colleague
NDA 020928 describes GLUCAGON, which is a drug marketed by Amphastar Pharms Inc, Lilly, and Fresenius Kabi Usa, and is included in four NDAs. It is available from four suppliers. Additional details are available on the GLUCAGON profile page.
The generic ingredient in GLUCAGON is glucagon hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
The generic ingredient in GLUCAGON is glucagon hydrochloride. There are twelve drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glucagon hydrochloride profile page.
Medical Subject Heading (MeSH) Categories for 020928
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 1MG/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Sep 11, 1998 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
